Both in Pharmaceuticals
ABBVIE vs Eli Lilly &
Over the past year ABBV returned +35.2% and LLY returned +64.3%; their daily moves had a correlation of 0.41.
ABBV +35.2% LLY +64.3%Growth of $1, one year, split-adjusted
| Metric | ABBV | LLY |
|---|---|---|
| Price | $294.89 | $1,417.54 |
| Market cap | $521.11B | $1.26T |
| Today | +1.41% | +3.19% |
| 1 month | +13.4% | +23.3% |
| 6 months | +42.7% | +47.1% |
| Year to date | +29.1% | +31.9% |
| 1 year | +31.0% | +74.2% |
| Revenue growth (YoY) | +10.2% | +38.6% |
| Gross margin | 74.7% | 83.9% |
| Net margin | 21.3% | 26.4% |
| P/E (TTM) | 82.8× | 45.8× |
| Price / sales | 8.1× | 14.6× |
| Net cash | -$64.25B | -$44.62B |
| Dividend yield | 2.35% | 0.49% |
| Volatility (60d) | 19.6% | 30.8% |
| Short % of float | 0.9% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).